Danaher Reports First Quarter 2020 Results

WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended April 3, 2020.  All results in this release reflect only continuing operations unless otherwise noted. For the first quarter 2020, net earnings were $595.1 million, or $0.81 per diluted common share.  Non-GAAP adjusted diluted net earnings... Read more

PerkinElmer Announces Financial Results for the First Quarter of 2020

Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the... Read more

Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development

SAN DIEGO–(BUSINESS WIRE)–Illumina (NASDAQ: ILMN) today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic. Dr. Aravanis will join Illumina in early June... Read more

Illumina Reports Financial Results for First Quarter of Fiscal Year 2020

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2020. First quarter 2020 results: Revenue of $859 million, a 2% increase compared to $846 million in the first quarter of 2019 GAAP net income attributable to Illumina stockholders for the quarter of $173 million, or $1.17... Read more

Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition

Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition WASHINGTON, April 30, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards, single use tangential flow filtration systems, and stainless steel... Read more

Le don d’Illumina au Centre africain de contrôle et de prévention des maladies étend ses capacités de surveillance du COVID-19 basée sur le séquençage

SAN DIEGO–(BUSINESS WIRE)–La société Illumina, Inc. (NASDAQ : ILMN) est heureuse d’annoncer que la Commission de l’union africaine, au nom du Centre africain pour le contrôle et la prévention des maladies (Center for Disease Control, CDC), reçoit un don à hauteur de 1,4 million USD de nos systèmes de séquençage et produits consommables connexes pour... Read more

WITec Reveals New Generation alpha300 apyron – Automated Raman Imaging Microscope with AutoBeam™ Technology.

Self-aligning, self-optimizing system keeps the focus on results. Ulm, Germany  April 28th, 2020 WITec GmbH, pioneer of Raman imaging and correlative microscopy, establishes the next level of automation and user-friendliness with the introduction of the new alpha300 apyron. Its AutoBeam technology unlocks the full potential of WITec’s industry-leading alpha300 series. The alpha300 apyron’s entirely new... Read more

New Blood Test Helps Clinicians Pinpoint A Potentially Life-Threatening Sensitization to Insect Stings

New Blood Test Helps Clinicians Pinpoint A Potentially Life-Threatening Sensitization to Insect Stings Thermo Scientific ImmunoCAP Specific IgE Stinging Insect Allergen Components identify patients’ sensitization to specific proteins in insect venom that may cause anaphylaxis and other allergic symptoms PORTAGE, Mich., April 27, 2020 /PRNewswire/ — ImmunoCAP Specific IgE Stinging Insect Allergen Components have been... Read more

Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call

Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call WASHINGTON, April 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced today that for the quarter ended April 3, 2020 it expects revenue growth of approximately 3.0% and non-GAAP core revenue growth of approximately 4.5%.... Read more